Skip to content
Back Home
  • Home
  • About Us
    • Our History
    • Our Science
    • Our Partners
  • Scientific Platforms
    • ADCs
    • Publications
  • Team
  • News
  • Contact
Back Home
  • Search
  • Home
  • About Us
    • Our History
    • Our Science
    • Our Partners
  • Scientific Platforms
    • ADCs
    • Publications
  • Team
  • News
  • Contact
Home » Uncategorized » Manhattan BioSolutions secures non-dilutive angel funding
Uncategorized

Manhattan BioSolutions secures non-dilutive angel funding

by Mbio2018|Published May 1, 2018

You may also like

Published July 1, 2018

Manhattan BioSolutions has won prestigious Johnson & Johnson Innovation QuickFire Challenge Competition and award to receive free laboratory and office space at the newly open JLabs@NYC incubator in downtown Manhattan

https://jlabs.jnjinnovation.com/quickfire-challenges/jlabs-nyc-quickfire-challenge#paragraph-5131 https://www.prnewswire.com/news-releases/johnson–johnson-innovation-opens-jlabs–nyc-in-collaboration-with-new-york-state-and-the-new-york-genome-center-300670313.html

Published December 19, 2023

Manhattan BioSolutions Named as an Awardee of Science in the City QuickFire Challenge

Published January 13, 2021

Manhattan BioSolutions to Present at the ACCESS CHINA Forum @JPM WEEK 2021

NEW YORK, NEW YORK, UNITED STATES, January 13, 2021 – Manhattan BioSolutions, Inc. (MABS), an emerging biotechnology company focused on the discovery […]

Published January 30, 2025

Manhattan BioSolutions Initiates NCI PIVOT Collaboration in Pediatric Cancers

Post navigation

  • Back to post list
  • Next post Manhattan BioSolutions has been awarded REACH grant from the New York State Center For Biotechnology at the Stony Brook University

© 2026 Manhattan BioSolutions – All rights reserved

Powered by WP – Designed with the Customizr theme